NURS 5455 Exam 2 NEWEST 2025/2026 COMPLETE 200
QUESTIONS AND CORRECT DETAILED ANSWERS
(VERIFIED ANSWERS) |ALREADY GRADED A+||BRAND
NEW!!
SYSTOLIC HEART FAILURE - CORRECT ANSWER-HEART FAILURE WITH A REDUCE
EJECTION FRACTION <40%
NORMAL JVD VALUE - CORRECT ANSWER-<4 CM
LEFT VENTRICULAR HEART FAILURE S/S - CORRECT ANSWER-EXERTIONAL DYSPNEA
COUGH
PND
ORTHOPNEA
FATIGUE
CAD PATHO - CORRECT ANSWER-ACCUMULATION OF PLAQUES INSIDE THE ARTERIES
CAUSING INFLAMMATORY RESPONSES, LEADING TO BLOCKAGES AND RUPTURES
OF THE ARTERIES
,BETA BLOCKER - CORRECT ANSWER-ANTI-ANGINAL AGENT DEMONSTRATED TO
PROLONG LIFE IN PATIENT WITH CAD POST MI
FRAMINGHAM TOOL - CORRECT ANSWER-TOOL USED TO ASSESS A PATIENTS 10 YEAR
RISK OF DEVELOPING CORONARY HEART DISEASE
CAD RISK FACTORS - CORRECT ANSWER-DM
HTN
TOBACCO
EKG CHANGES WITH ACUTE MI - CORRECT ANSWER-ST SEGMENT ELEVATION >/= TO
4 MM
EKG CHANGE INDICATING MYOCARDIAL ISCHEMIA - CORRECT ANSWER-ST-SEGMENT
DEPRESSION OR T-WAVE INVERSION
DIAGNOSTIC TESTING FOR ACUTE MI - CORRECT ANSWER-CK-MB, MYOHLOBIN,
TROPONIN
ECHO
RADIONUCLIDE IMAGING
HIGHEST RISK FACTOR FOR INFECTIVE ENDOCARDITIS - CORRECT ANSWER-IV DRUG
ABUSE
, PRINZMETAL'S ANGINA - CORRECT ANSWER-CHEST PAIN OFTEN AWAKENING IN THE
MORNING
DIAGNOSTIC TEST OF CHOICE FOR DETECTING HYPERTROPHIC CARDIOMYOPATHY
(HCM) OR IDOPATHIC LEFT VENTRICULAR HYPERTROPHY (LVH) IS - CORRECT
ANSWER-ECHO
IN A PATIENT WITH HYPERTROPHIC CARDIOMYOPATHY WITH END-STAGE
SYSTOLIC HEART FAILURE, WHICH AGENTS ARE USED FOR DISEASE
MANAGEMENT - CORRECT ANSWER-DIGOXIN
ORAL ANTICOAGULANTS
ACEI/ARB
DIURETIC
BETA BLOCKER
A PATIENT PRESENTS WITH HYPERLIPIDEMIA AND UNSTABLE ANGINA. YOUR
NEXT ACTION WOULD BE: - CORRECT ANSWER-SEND TO ACUTE CARE FOR WORK-UP
OF ISCHEMIA, ARRYTHMIA, OR THROMBOSIS
WHICH OF THE FOLLOWING AGENTS WOULD BE CONSIDERED AS FIRST-LINE
THERAPY FOR A CLIENT WITH STAGE 2 HTN AND HEART FAILURE - CORRECT ANSWER-
TELMISARTAN
HOW MANY AMERICANS WILL LIKELY HAVE A HEART ATTACK FOR THE FIRST TIME
THIS YEAR - CORRECT ANSWER-> 600,000
QUESTIONS AND CORRECT DETAILED ANSWERS
(VERIFIED ANSWERS) |ALREADY GRADED A+||BRAND
NEW!!
SYSTOLIC HEART FAILURE - CORRECT ANSWER-HEART FAILURE WITH A REDUCE
EJECTION FRACTION <40%
NORMAL JVD VALUE - CORRECT ANSWER-<4 CM
LEFT VENTRICULAR HEART FAILURE S/S - CORRECT ANSWER-EXERTIONAL DYSPNEA
COUGH
PND
ORTHOPNEA
FATIGUE
CAD PATHO - CORRECT ANSWER-ACCUMULATION OF PLAQUES INSIDE THE ARTERIES
CAUSING INFLAMMATORY RESPONSES, LEADING TO BLOCKAGES AND RUPTURES
OF THE ARTERIES
,BETA BLOCKER - CORRECT ANSWER-ANTI-ANGINAL AGENT DEMONSTRATED TO
PROLONG LIFE IN PATIENT WITH CAD POST MI
FRAMINGHAM TOOL - CORRECT ANSWER-TOOL USED TO ASSESS A PATIENTS 10 YEAR
RISK OF DEVELOPING CORONARY HEART DISEASE
CAD RISK FACTORS - CORRECT ANSWER-DM
HTN
TOBACCO
EKG CHANGES WITH ACUTE MI - CORRECT ANSWER-ST SEGMENT ELEVATION >/= TO
4 MM
EKG CHANGE INDICATING MYOCARDIAL ISCHEMIA - CORRECT ANSWER-ST-SEGMENT
DEPRESSION OR T-WAVE INVERSION
DIAGNOSTIC TESTING FOR ACUTE MI - CORRECT ANSWER-CK-MB, MYOHLOBIN,
TROPONIN
ECHO
RADIONUCLIDE IMAGING
HIGHEST RISK FACTOR FOR INFECTIVE ENDOCARDITIS - CORRECT ANSWER-IV DRUG
ABUSE
, PRINZMETAL'S ANGINA - CORRECT ANSWER-CHEST PAIN OFTEN AWAKENING IN THE
MORNING
DIAGNOSTIC TEST OF CHOICE FOR DETECTING HYPERTROPHIC CARDIOMYOPATHY
(HCM) OR IDOPATHIC LEFT VENTRICULAR HYPERTROPHY (LVH) IS - CORRECT
ANSWER-ECHO
IN A PATIENT WITH HYPERTROPHIC CARDIOMYOPATHY WITH END-STAGE
SYSTOLIC HEART FAILURE, WHICH AGENTS ARE USED FOR DISEASE
MANAGEMENT - CORRECT ANSWER-DIGOXIN
ORAL ANTICOAGULANTS
ACEI/ARB
DIURETIC
BETA BLOCKER
A PATIENT PRESENTS WITH HYPERLIPIDEMIA AND UNSTABLE ANGINA. YOUR
NEXT ACTION WOULD BE: - CORRECT ANSWER-SEND TO ACUTE CARE FOR WORK-UP
OF ISCHEMIA, ARRYTHMIA, OR THROMBOSIS
WHICH OF THE FOLLOWING AGENTS WOULD BE CONSIDERED AS FIRST-LINE
THERAPY FOR A CLIENT WITH STAGE 2 HTN AND HEART FAILURE - CORRECT ANSWER-
TELMISARTAN
HOW MANY AMERICANS WILL LIKELY HAVE A HEART ATTACK FOR THE FIRST TIME
THIS YEAR - CORRECT ANSWER-> 600,000
